This updated meta-analysis was performed to clarify the relationship between phytoestrogens and prostate cancer risk. Twenty one case-control and two cohort studies were finally selected for this meta-analysis, totaling 11,346 cases and 140,177 controls. Analytical results showed that daidzein (OR = 0.85; 95% CI: 0.75-0.96), genistein (OR = 0.87; 95% CI: 0.78-0.98), and glycitein (OR = 0.89; 95% CI: 0.81-0.98) were associated with a reduction of prostate cancer risk, but total isoflavones (OR = 0.93; 95% CI: 0.84-1.04), equol (OR = 0.86; 95% CI: 0.66-1.14), total lignans (OROgna.05; 95% CI: 0.54-2.04), secoisolariciresinol (OR = 1.02; 95% CI: 0.83-1.24), matairesinol (OR = 0.91; 95% CI: 0.75-1.11), enterolactone (OR = 0.94; 95% CI: 0.73-1.20), and coumestrol (OR = 0.89; 95% CI: 0.76-1.06) were not. Sensitivity and publication bias analyses demonstrated that the pooled estimates were stable and reliable. The results support the notion that some phytoestrogens may have a role in decreasing the risk of prostate cancer. Additional large and well-designed cohort studies are needed to confirm these relationships.
International journal of food sciences and nutrition. 2016 Aug 09 [Epub ahead of print]
Qiang Zhang, Hongliang Feng, Bakare Qluwakemi, Jiaqi Wang, Songpo Yao, Guangdong Cheng, Hui Xu, Hongbin Qiu, Liling Zhu, Mingxia Yuan
a School of Public Health, Jiamusi University , Jiamusi , China ;, c College of Life Science, Jiamusi University , Jiamusi , China ;, d College of Basic Medicine, Jiamusi University , Jiamusi , China ;, e Bio-Vaccine Limited Liability Company, Harbin Pharmaceutical Group , Harbin , China.